BioCentury | Dec 12, 2020
Finance

Forbion to focus record €460M fund on early-stage opportunities

...least two other European life sciences VCs — LSP and Gilde Healthcare...
BioCentury | Dec 2, 2020
Emerging Company Profile

Sofinnova’s Papiernik, Costa and Roche alum Garibaldi carve orphan neurology play Noema out of the pharma’s assets

...does not have plans to perform drug discovery. Gilde Healthcare...
...million ($59.3 million)Investors: Sofinnova Partners, Polaris Partners, Gilde Healthcare...
...5 (mGluR5) (GRM5)Phosphodiesterase-10A (PDE-10A) Danielle Golovin Tegretol, carbamazepine Sofinnova Partners Polaris Partners Gilde Healthcare Invus Boston...
BioCentury | Sep 18, 2020
Finance

Lava’s $83M series C exemplifies evolution of Novo Ventures’ investing

...investors Redmile Group, Ysios Capital and BB Pureos Bioventures as well as returning investors Versant Ventures, Gilde Healthcare...
BioCentury | Sep 1, 2020
Politics, Policy & Law

FDA’s credibility on the line, plus biotech’s venture wave and a Back to School preview: a BioCentury podcast

...investing in European companies, such as Andera Partners, Gilde Healthcare...
...next year. And we saw LSP and Gilde Healthcare...
BioCentury | Aug 6, 2020
Finance

‘Not drip-feeding’: Andera looks to deploy record €450M fund to mostly European biotechs

...European VCs have raised large funds this year, with at least two -- LSP and Gilde Healthcare...
BioCentury | Mar 31, 2020
Finance

With new $450M fund, Gilde is latest European firm to aim for bigger holdings in earlier-stage investments

...With its largest venture and growth capital fund to date, a $450 million vehicle, Gilde Healthcare is...
...the firm is now aiming to own larger minority positions that could exceed 30% via Gilde Healthcare...
BioCentury | Feb 28, 2020
Emerging Company Profile

Lava: better safety for bispecifics with γδ T cell engagement

...partners: None Number of employees: 23 Funds raised: €17 million ($18.4 million) Investors: Biox Biosciences, Gilde Healthcare...
BioCentury | Nov 8, 2019
Finance

Van Herk’s DCprime ready to boost its cell-based cancer vaccine

...in private companies directly or as an LP in venture funds including funds from Forbion, Gilde Healthcare...
BioCentury | Jul 16, 2019
Finance

As it preps Phase III kidney trial on its own, AM-Pharma raises €116M series C

...Partners and existing investors Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare....
BioCentury | Jun 26, 2019
Financial News

Spain’s Sanifit heads to Phase III with €72.2M in new funding

...Partners and Alta Life Sciences. Also participating were returning investors Lundbeckfonden Ventures, Ysios Capital, Forbion, Gilde Healthcare...
Items per page:
1 - 10 of 82
BioCentury | Dec 12, 2020
Finance

Forbion to focus record €460M fund on early-stage opportunities

...least two other European life sciences VCs — LSP and Gilde Healthcare...
BioCentury | Dec 2, 2020
Emerging Company Profile

Sofinnova’s Papiernik, Costa and Roche alum Garibaldi carve orphan neurology play Noema out of the pharma’s assets

...does not have plans to perform drug discovery. Gilde Healthcare...
...million ($59.3 million)Investors: Sofinnova Partners, Polaris Partners, Gilde Healthcare...
...5 (mGluR5) (GRM5)Phosphodiesterase-10A (PDE-10A) Danielle Golovin Tegretol, carbamazepine Sofinnova Partners Polaris Partners Gilde Healthcare Invus Boston...
BioCentury | Sep 18, 2020
Finance

Lava’s $83M series C exemplifies evolution of Novo Ventures’ investing

...investors Redmile Group, Ysios Capital and BB Pureos Bioventures as well as returning investors Versant Ventures, Gilde Healthcare...
BioCentury | Sep 1, 2020
Politics, Policy & Law

FDA’s credibility on the line, plus biotech’s venture wave and a Back to School preview: a BioCentury podcast

...investing in European companies, such as Andera Partners, Gilde Healthcare...
...next year. And we saw LSP and Gilde Healthcare...
BioCentury | Aug 6, 2020
Finance

‘Not drip-feeding’: Andera looks to deploy record €450M fund to mostly European biotechs

...European VCs have raised large funds this year, with at least two -- LSP and Gilde Healthcare...
BioCentury | Mar 31, 2020
Finance

With new $450M fund, Gilde is latest European firm to aim for bigger holdings in earlier-stage investments

...With its largest venture and growth capital fund to date, a $450 million vehicle, Gilde Healthcare is...
...the firm is now aiming to own larger minority positions that could exceed 30% via Gilde Healthcare...
BioCentury | Feb 28, 2020
Emerging Company Profile

Lava: better safety for bispecifics with γδ T cell engagement

...partners: None Number of employees: 23 Funds raised: €17 million ($18.4 million) Investors: Biox Biosciences, Gilde Healthcare...
BioCentury | Nov 8, 2019
Finance

Van Herk’s DCprime ready to boost its cell-based cancer vaccine

...in private companies directly or as an LP in venture funds including funds from Forbion, Gilde Healthcare...
BioCentury | Jul 16, 2019
Finance

As it preps Phase III kidney trial on its own, AM-Pharma raises €116M series C

...Partners and existing investors Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare....
BioCentury | Jun 26, 2019
Financial News

Spain’s Sanifit heads to Phase III with €72.2M in new funding

...Partners and Alta Life Sciences. Also participating were returning investors Lundbeckfonden Ventures, Ysios Capital, Forbion, Gilde Healthcare...
Items per page:
1 - 10 of 82